{"id":"W3204898243","doi":"10.1016/j.annonc.2021.08.1863","title":"1260P Clinical outcomes of patients with BRAFv⁶⁰⁰-mutated metastatic NSCLC (mNSCLC) receiving first-line (1L) dabrafenib-trametinib vs other standard of care in real-world practice","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Novartis (Canada); University of British Columbia","funders":"EMD Serono; Merck KGaA","keywords":"Dabrafenib; Trametinib; Medicine; Oncology; Internal medicine; Standard of care; First line; Metastatic melanoma; Vemurafenib; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004747771,0.0001332299,0.0003934115,0.0003407373,0.0002794016,0.000844962,0.000254377,0.0004632578,0.002320021],"category_scores_gemma":[0.002823097,0.0001291867,0.0006254397,0.0007153538,0.0002439117,0.0006177136,0.000423543,0.0006266551,0.0002918243],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00104055,"about_ca_system_score_gemma":0.0005596119,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00412142,"about_ca_topic_score_gemma":0.008738195,"domain_scores_codex":[0.999534,0.0001195022,0.00005039343,0.0001253049,0.00006898944,0.0001018425],"domain_scores_gemma":[0.9987098,0.000206181,0.0006186719,0.0000319987,0.0001014298,0.0003318274],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005360231,0.0002563019,0.9665557,0.0001275447,0.0004506672,0.0002133276,0.0001133113,0.0004529057,0.0002928135,0.0001179243,0.00226198,0.02379748],"study_design_scores_gemma":[0.0005174004,0.001913567,0.9938211,0.00006585383,0.0003383626,0.0005595846,0.0003166771,0.000790934,0.0001313333,0.0001899772,0.001335517,0.00001972411],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958072,0.001074333,0.00004197639,0.0004284283,0.00002777085,0.00001745687,0.001306583,0.000005546051,0.001290778],"genre_scores_gemma":[0.9984433,0.0002811484,0.00004094946,0.0001267871,0.00003222431,0.00000920744,0.0008789996,0.000001513773,0.0001859274],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00412142,"threshold_uncertainty_score":0.008194864,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08867224204008321,"score_gpt":0.4538473843707594,"score_spread":0.3651751423306762,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}